Imidaprilat

Imidaprilat

SCHEMBL677222

C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACE P12821 16/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Imidaprilat SCHEMBL7338400 1.00 ACE (1.00) ACE
Imidaprilat SCHEMBL683544 1.00 ACE (1.00) ACE
Imidaprilat SCHEMBL7297440 0.99 ACE (0.98) ACE
Imidaprilat SCHEMBL7265368 0.99 ACE (0.98) ACE
Imidaprilat SCHEMBL7313750 0.99 ACE (0.98) ACE
Imidaprilat SCHEMBL28579102 0.99 ACE (0.98) ACE
SCHEMBL683529 0.91 ACE (0.87) ACE
SCHEMBL683274 0.91 ACE (0.87) ACE
SCHEMBL683904 0.91 ACE (0.83) ACE
Imidapril SCHEMBL22492310 0.90 ACE (1.00) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250082608-A1 TREATMENT AND PREVENTION OF GLOMERULAR DISEASE SINGAPORE HEALTH SERVICES PTE LTD. (SG) 2025-03-13 US claimed
EP-4448096-A1 TREATMENT AND PREVENTION OF GLOMERULAR DISEASE Singapore Health Services Pte. Ltd. (SG) 2024-10-23 EP claimed
WO-2023111196-A1 TREATMENT AND PREVENTION OF GLOMERULAR DISEASE SINGAPORE HEALTH SERVICES PTE. LTD. (SG) 2023-06-22 WO claimed
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
CN-1659154-B Process for the preparation of amine stereoisomers APSINTERM LLC 2012-05-30 CN claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
CN-101330905-A Freeze-drying process and products obtained thereby SCIDOSE LLC (US) 2008-12-24 CN claimed
EP-1954244-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY Scidose, Llc (US) 2008-08-13 EP claimed
WO-2007061529-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. (US) 2007-05-31 WO claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
WO-2005010028-A1 ALPHA-AMINO ACID BENZOTHIAZOLYLTHIO ESTER AS INTERMEDIATES FOR MANUFACTURE OF ACE INHIBITORS AND PROCESS FOR PREPARATION THEREOF LUPIN LIMITED (IN) 2005-02-03 WO claimed
EP-1497272-A2 METHOD OF PREPARING AMINE STEREOISOMERS Apsinterm, LLC. (US) 2005-01-19 EP claimed
WO-2003091207-A2 METHOD OF PREPARING AMINE STEREOISOMERS APSINTERM, LLC. (US) 2003-11-06 WO claimed
EP-0274230-B1 USE OF 2-OXO-IMIDAZOLIDINE DERIVATIVES IN THE PROPHYLAXIS AND TREATMENT OF HEART FAILURE TANABE SEIYAKU CO., LTD. (JP) 1992-10-14 EP claimed
EP-0272849-B1 USE OF 2-OXO-IMIDAZOLIDINE DERIVATIVES IN THE TREATMENT OF KIDNEY DISEASES Tanabe Seiyaku Co., Ltd. (JP) 1992-10-14 EP claimed
US-4888339-A CARDIOTONIC AGENTS; 2-OXOIMIDAZOLIDINE TANABE SEIYAKU CO., LTD. (JP) 1989-12-19 US claimed
US-4804672-A UROGENITIAL DISORDERS TANABE SEIYAKU CO., LTD. (JP) 1989-02-14 US claimed
EP-0274230-A2 Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure TANABE SEIYAKU CO., LTD. (JP) 1988-07-13 EP claimed
EP-0272849-A2 Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases Tanabe Seiyaku Co., Ltd. (JP) 1988-06-29 EP claimed
EP-0095163-A2 2-Oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition Tanabe Seiyaku Co., Ltd. (JP) 1983-11-30 EP claimed